Guardant Health Inc.

NASDAQ: GH
Share price (11/21/24): $30.98
Market cap (11/21/24): $3.828 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Potter Myrtle S

Joyce Meghan V.

News Filter

Revenue Growth of 34% Driven by Strong Clinical and Biopharma Volume and Guardant360 ASP Tailwinds

Roberto A. Mignone Joins Guardant Health Board of Directors

Material Definitive Agreement, Financial Statements or Exhibits

Revenue Growth of 29% Driven by Strong Clinical and Biopharma Volume and Guardant360 ASP Tailwinds Shield Approved by FDA as Primary Option for CRC Screening and Is Commercially Available in U.S

ShieldTM Blood Test Approved by FDA as a Primary Screening Option, Clearing Path for Medicare Reimbursement and a New Era of Colorectal Cancer Screening

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC